Global Narcolepsy Drugs Market

Global Narcolepsy Drugs Market Size, Share, Growth Analysis, By Narcolepsy Type(Cataplexy, and Daytime Extreme Sleepiness.), By Therapeutics(Psychostimulants, Tricyclic Antidepressants), By End User(Hospitals, and Diagnostic Centres. ) - Industry Forecast 2023-2030


Report ID: SQMIG35I2087 | Region: Global | Published Date: February, 2024 | Pages: 246 | Tables: 90 | Figures: 75

Global Narcolepsy Drugs Market Insights

Global Narcolepsy Drugs Market size was valued at USD 2680.06 million in 2021 and is poised to grow from USD 2937.35 million in 2022 to USD 6115.61 million by 2030, growing at a CAGR of 9.6% in the forecast period (2023-2030).

The market is primarily driven by the aging population, and their vulnerability to various chronic and acute diseases that require medical care.The rise in narcoleptic diseases, changing lifestyles, and the rise in stress levels, which cause narcolepsy disorder are also projected to aid in market expansion during the forecast period. Furthermore, the narcolepsy therapeutics market is projected to witness significant growth in the coming years owing to increase in research efforts, rise in healthcare expenditure,, and the presence of enhanced medical infrastructure.

The symptoms of central hypersomnia can be controlled by circadian delay, more sleep, and teleworking. Due to the low consumption of narcolepsy treatments and the public's desire for better sleep circumstances, the narcolepsy drugs market is projected to witness significant growth in the coming years.

On the other hand, high expenses and a lack of knowledge about the availability of treatment for narcolepsy may limit market expansion in the future. In addition to this, high treatment and diagnostic costs as well as an unfavourable reimbursement environment are the factors that will restrain market expansion. The narcolepsy treatment market would face challenges throughout the forecast period due to decreased operating revenue opportunities for targeted therapy research and development by various pharmaceuticals.

US Narcolepsy Drugs Market  is poised to grow at a sustainable CAGR for the next forecast year.

Market snapshot - 2023-2030

Global Market Size

USD 2680.06 million

Largest Segment

Hospitals

Growth Rate

9.6% CAGR

Global Narcolepsy Drugs Market 2022-2030 ($ Bn)
Country Share for North America Region- 2022 (%)
Global Naroclepsy Drugs Market Size By End User, 2022-2030 ($ Bn)
Global Narcolepsy Drugs Market Size By End User 2022-2030 (%)

To get more reports on the above market click here to Buy The Report

Global Narcolepsy Drugs Market Segmental Analysis

Global Narcolepsy Drugs Market is segmented based on the narcolepsy type, therapeutics, end user and region. In terms of narcolepsy type, the market is segmented into cataplexy, and daytime extreme sleepiness. With respect to segmentation by therapeutics, the Narcolepsy Drugs Market is categorized into psychostimulants, tricyclic antidepressants, sodium oxybate, selective serotonin reuptake inhibitors, and central nervous system stimulants. The End User segment is further classified into hospitals, and diagnostic centres. Region Wise, the Narcolepsy Drugs Market is widespread into North America, Europe, Asia-Pacific, Latin America, and MEA.

Narcolepsy Drugs Market Analysis by Therapeutics:

The market is segmented into central nervous system stimulants, sodium oxybate, tricyclic antidepressants, selective serotonin reuptake inhibitors, and others based on therapeutic kind. Due to its great efficacy in treating cataplexy and excessive daytime drowsiness, the existence of advantageous reimbursement policies, and growing public knowledge of diagnosis and related therapies, sodium oxybate is anticipated to register the highest CAGR throughout the projection period.

Narcolepsy Drugs Market Analysis by End User:

Due to the increased use of polysomnography, numerous sleep latency tests, and other diagnostic tests to diagnose narcolepsy patients, the hospitals segment held the largest share in the market. During a polysomnographic study, the patient's brain waves, blood oxygen levels, heart rate, breathing, and eye and leg movements are all recorded. If a patient has previously been diagnosed with a sleep problem, polysomnography can be utilized to help modify the treatment plan in addition to narcolepsy diagnostics. Additionally, it is typically carried out at sleep centres or hospital units that deal with sleep disorders.

Global Narcolepsy Drugs Market By End-user 2022 (%), 2021 (%)

To get detailed analysis on other segments, Request For Sample Report

Global Narcolepsy Drugs Market Regional Insights

The market in North America is expected to continue dominating the market and derive benefits from factors such as higher healthcare expenditure, presence of strong global players, and favourable reimbursement policy structure. The high prevalence rate of narcolepsy in the United States and Canada are further expected to help attract significant revenues for this region. A strong clinical pipeline also helps to sustain the local narcolepsy medication industry. A sizable portion of the population still has at least one sleep-related condition, which is expected to maintain the market's potential for growth higher in North America.

Due to the expansion of healthcare infrastructure in nations such as India, the Asia Pacific region is predicted to experience moderate growth in the worldwide market in the future. A further factor that may support market expansion in the Asia Pacific region is the strengthening of healthcare reimbursement regulations in developing nations.

Global Narcolepsy Drugs Market By Geography, 2022-2030, 2023-2030
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Global Narcolepsy Drugs Market Dynamics

Narcolepsy Drugs Market Drivers

Increasing Awareness of Narcolepsy Treatment

  • Growing awareness of narcolepsy treatment is a significant driver propelling the narcolepsy market from 2023 to 2030. Additionally, since modafinil has fewer adverse effects than other stimulants, using it to treat patients is boosting the demand for it. Therefore, the adoption of suitable therapy can aid in the prevention of such diseases, propelling the narcolepsy market from 2022 to 2026.

Rise in The Number of Narcolepsy Patient

  • An important element driving the narcolepsy market from 2022 to 2027 will be the increase in narcolepsy patients. Additionally, the Narcolepsy Network estimates that 1 in every 2,000 Americans has narcolepsy.

Narcolepsy Drugs Market Restraint

Lack of Awareness

  • Narcolepsy symptoms are frequently confused with those of other mental and neurological conditions due to a lack of awareness. As a result, antiepileptics and psychiatric medications are frequently prescribed, which can be harmful to children's and adolescents' health.

Speak to one of our ABIRAW analyst for your custom requirements before the purchase of this report

Global Narcolepsy Drugs Market Competitive Landscape

The competitive landscape of the narcolepsy treatment market gives information by competitor. Company overview, financials, revenue generated, market potential, investments in R&D, new market initiatives, global presence, production facilities, company strengths and weaknesses, product launch, clinical trial pipelines, product approvals, patents, product width and breadth, application dominance, and technology lifeline curve are among the details provided. The aforementioned data points are limited to the companies' market research focus on narcolepsy treatment.

Narcolepsy Drugs Market Top Player's Company Profiles

  • Jazz Pharmaceuticals
  • Teva Pharmaceutical Industries
  • Novartis
  • Mylan N.V.
  • Shire Pharmaceuticals (acquired by Takeda Pharmaceutical Company Limited)
  • Ligand Pharmaceuticals
  • Bioprojet SCR
  • Arena Pharmaceuticals
  • Avadel Pharmaceuticals
  • Graymark Healthcare
  • Balance Pharmaceuticals
  • Theravance Biopharma
  • Biocodex
  • Flamel Technologies
  • Otsuka Pharmaceutical
  • Biogen
  • Aurobindo Pharma
  • Glenmark Pharmaceuticals
  • Lupin Pharmaceuticals

Narcolepsy Drugs Market Recent Developments

  • In 2022, The FDA approved the new drug application (NDA) submitted by Avadel Pharmaceuticals for the investigational medication FT218 to treat excessive daytime sleepiness and cataplexy in narcoleptic adults.
  • In 2022, A phase 3 study presented by a Stanford researcher demonstrated how sodium oxybate extended release helps narcolepsy patients by reducing daytime sleepiness and improving muscle weakness.

Global Narcolepsy Drugs Key Market Trends

The market growth driver for the narcolepsy market is the increasing prevalence of narcolepsy among various population segments worldwide. An increase in the number of persons experiencing various sleep disorders and hallucinations would have a positive impact on the global market for narcolepsy drugs. Additionally, the rise in obesity rates worldwide are anticipated to support future growth in the global narcolepsy market. In the coming years, it is anticipated that government initiatives and steps to raise awareness of narcolepsy would increase demand for narcolepsy products. The end-use category for hospitals is anticipated to contribute the most to the overall market because of the rise in narcolepsy patients seeking treatment at these facilities.

Global Narcolepsy Drugs Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected utilizing Primary Exploratory Research backed by the robust Secondary Desk research.

According to SkyQuest, the global market for pharmaceuticals includes the market for narcolepsy medications. The degrees of growth of the narcolepsy medications market over the projected period will be determined by external factors impacting the parent market growth potential in the ensuing years, which have been extensively discussed in our research report.

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to a detailed SkyQuest exclusive matrix.

Report Metric Details
Market size value in 2021 USD 2680.06 million
Market size value in 2030 USD 2937.35 million
Growth Rate 9.6%
Base year 2021
Forecast period 2023-2030
Forecast Unit (Value) USD Million
Segments covered
  • Narcolepsy Type
    • Cataplexy, and Daytime Extreme Sleepiness.
  • Therapeutics
    • Psychostimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitors, Central Nervous System Stimulants.
  • End User
    • Hospitals, and Diagnostic Centres. 
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Jazz Pharmaceuticals
  • Teva Pharmaceutical Industries
  • Novartis
  • Mylan N.V.
  • Shire Pharmaceuticals (acquired by Takeda Pharmaceutical Company Limited)
  • Ligand Pharmaceuticals
  • Bioprojet SCR
  • Arena Pharmaceuticals
  • Avadel Pharmaceuticals
  • Graymark Healthcare
  • Balance Pharmaceuticals
  • Theravance Biopharma
  • Biocodex
  • Flamel Technologies
  • Otsuka Pharmaceutical
  • Biogen
  • Aurobindo Pharma
  • Glenmark Pharmaceuticals
  • Lupin Pharmaceuticals
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Global Narcolepsy Drugs Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Global Narcolepsy Drugs Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Global Narcolepsy Drugs Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Narcolepsy Drugs Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Narcolepsy Drugs Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Global Narcolepsy Drugs Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

SPEAK TO AN ANALYST

FAQ's

Global Narcolepsy Drugs Market size was valued at USD 2680.06 million in 2021 and is poised to grow from USD 2937.35 million in 2022 to USD 6115.61 million by 2030, growing at a CAGR of 9.6% in the forecast period (2023-2030).

The competitive landscape of the narcolepsy treatment market gives information by competitor. Company overview, financials, revenue generated, market potential, investments in R&D, new market initiatives, global presence, production facilities, company strengths and weaknesses, product launch, clinical trial pipelines, product approvals, patents, product width and breadth, application dominance, and technology lifeline curve are among the details provided. The aforementioned data points are limited to the companies' market research focus on narcolepsy treatment. 'Jazz Pharmaceuticals', 'Teva Pharmaceutical Industries', 'Novartis', 'Mylan N.V.', 'Shire Pharmaceuticals (acquired by Takeda Pharmaceutical Company Limited)', 'Ligand Pharmaceuticals', 'Bioprojet SCR', 'Arena Pharmaceuticals', 'Avadel Pharmaceuticals', 'Graymark Healthcare', 'Balance Pharmaceuticals', 'Theravance Biopharma', 'Biocodex', 'Flamel Technologies', 'Otsuka Pharmaceutical', 'Biogen', 'Aurobindo Pharma', 'Glenmark Pharmaceuticals', 'Lupin Pharmaceuticals'

Growing awareness of narcolepsy treatment is a significant driver propelling the narcolepsy market from 2023 to 2030. Additionally, since modafinil has fewer adverse effects than other stimulants, using it to treat patients is boosting the demand for it. Therefore, the adoption of suitable therapy can aid in the prevention of such diseases, propelling the narcolepsy market from 2022 to 2026.

The market in North America is expected to continue dominating the market and derive benefits from factors such as higher healthcare expenditure, presence of strong global players, and favourable reimbursement policy structure. The high prevalence rate of narcolepsy in the United States and Canada are further expected to help attract significant revenues for this region. A strong clinical pipeline also helps to sustain the local narcolepsy medication industry. A sizable portion of the population still has at least one sleep-related condition, which is expected to maintain the market's potential for growth higher in North America.

Speak With Our Analyst

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Narcolepsy Drugs Market

Product ID: SQMIG35I2087

$5,300
BUY NOW GET SAMPLE